Zotarolimus

CAS 221877-54-9 1 current recordSmall Molecule

Who holds supplier records for Zotarolimus? 1 organisation holds a current record for Zotarolimus: an active US FDA Type II Drug Master File.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 11 Nov 2026. How we read these records

Cite as: PharmaTek, “Zotarolimus: DMF and CEP holder records”, record as of 11 Nov 2026, pharmatek.co.uk/directory/api/zotarolimus

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Zotarolimus. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • MEDTRONIC VASCULAR GALWAY UNLTD CO
    Active DMF 16960 · latest filing Nov 2003
Need Zotarolimus sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Zotarolimus is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL219410).

Chemical identity

IUPAC name
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-12-[(2R)-1-[(1S,3R,4S)-3-methoxy-4-(tetrazol-1-yl)cyclohexyl]propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Canonical SMILES
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)N5C=NN=N5)C)/C)O)OC)C)C)/C)OC
InChIKey
CGTADGCBEXYWNE-JUKNQOCSSA-N
Synonyms
ABT-578, Mdt-4107, Zotarolimus, zotarilumus, ABT578, ABT 578, zotarolimusum, RefChem:196269, Endeavor, Zotarolimus, >90%, Zotarolimus [USAN:INN], A 179578

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Zotarolimus?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Zotarolimus: MEDTRONIC VASCULAR GALWAY UNLTD CO. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Zotarolimus Drug Master Files are active?

MEDTRONIC VASCULAR GALWAY UNLTD CO (DMF 16960). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Zotarolimus supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Zotarolimus?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.